Guizhou Sanli Pharmaceutical Co., Ltd. Class ASSE: 603439

Announcement on Attending the 2025 Investor Collective Meeting and 2024 Annual Performance Briefing of Listed Companies in Guizhou Jurisdiction and Soliciting Questions

· Issued by Guizhou Sanli Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Attending the 2025 Investor Collective Meeting and 2024 Annual Performance Briefing of Listed Companies in Guizhou Jurisdiction and Soliciting Questions

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis